Skip to main content

Market Overview

Stoke Therapeutics, Inc. (STOK)

37.71 -0.94 (-2.43%)

Analyst Ratings

DateResearch FirmActionCurrentPT
5/18/21UBSInitiates Coverage OnNeutral35.0
5/10/21WedbushUpgradesOutperform
3/11/21Canaccord GenuityMaintainsBuy76.0
3/10/21Credit SuisseMaintainsOutperform58.0
2/10/21WedbushDowngradesNeutral
1/14/21NeedhamMaintainsBuy65.0
12/28/20Canaccord GenuityMaintainsBuy72.0
12/15/20HC Wainwright & Co.AssumesBuy70.0
12/11/20NeedhamMaintainsBuy56.0
11/13/20Canaccord GenuityMaintainsBuy53.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter